Rationale: Regeneration of lost cardiomyocytes is a fundamental unresolved problem leading to heart failure.
A lthough recent findings suggest certain renewing potential, 1 the endogenous regeneration of cardiomyocytes is supposed to be extremely limited. 2 Different somatic cell types with a certain cardiogenic potential, including bone marrowderived cells, 3 peripheral blood stem cells, 4 endothelial progenitors, 5 and mesoangioblasts, 6 were reported. However, thus far, such cells could not be harnessed for myocardial regeneration in the clinical setting except studies reporting an improvement of some cardiac functions after transplantation of such cells in preclinical models. Therefore, exactly defined cardiogenic stem cell sources within the heart tissue would 
Methods and Results:

Sca-1 (stem cell antigen-1)-CD44
− AoCs as the population that gives rise to aortic wall-derived cardiomyocytes. This AoC subpopulation delivered also endothelial cells and macrophages with a particular accumulation within the aortic wall-derived cardiomyocyte containing colonies. In vivo, cardiomyocyte differentiation capacity was studied by implantation of fluorescently labeled AoCs into chick embryonic heart. These cells acquired cardiomyocyte-like phenotype as shown by αSRA (α-sarcomeric actinin) expression. Furthermore, coronary adventitial Flk1 + and CD34 + cells proliferated, migrated into the myocardium after mouse myocardial infarction, and expressed Isl-1 constitute a crucial step forward and are essential to establish new cardiac regenerative therapeutic strategies. 7 One promising niche might be the vascular adventitia, which has been shown to harbor various stem and progenitor cell types, [8] [9] [10] 
CD34
− cells that can give rise to endothelial and smooth muscle cells, as well as macrophages. [11] [12] [13] [14] In large arteries, adventitial stem and progenitor cells were shown to contribute to neointima formation 15, 16 and atherosclerosis. 17 Moreover, the vascular adventitia was reported to harbor progenitors for dendritic cells. 18 In addition, coronary vessels were shown to contain different subsets of multipotent stem cells, such as c-Kit 19 Finally, the development of coronary endothelial cell (EC)-derived cardiac progenitors was recently reported. 20 In this study, we demonstrate that the adventitia of mouse aorta, as well as human and mouse coronary vessels, harbors Sca-1 + aortic wall-derived cells (AoCs) formed colony-like structures under specific culture conditions, differentiated into spontaneously beating cardiomyocytes in vitro and achieved cardiomyocyte phenotype after implantation into the chick embryonic heart in vivo. Using AoCs from Flk1-reporter mice and magnetic bead-associated cell-sorted (MACS) Flk1 
+ subpopulation of AoCs as the source that gives rise to Ao-bCMs (aortic wall-derived beating cardiomyocytes). The presence of the subpopulation was also confirmed by flow cytometric analyses of freshly isolated AoCs. Furthermore, these cells also give rise to F4/80 + macrophages, the depletion of which prevented the generation of Ao-bCMs in vitro. Additionally, these macrophages were strongly positive for VEGF (vascular endothelial growth factor) and the blockage of the VEGF receptor Flk1 reduced the number of aortic wall-derived CD31 + ECs and inhibited also the generation of Ao-bCMs. Lastly, mouse and human coronary vessel-resident Flk1 + CD34
+ progenitors were mobilized from their adventitial niche, proliferated and became positive for cardiovascular progenitor marker Isl-1 (insulin gene enhancer protein-1) and in close vicinity to myocardial infarction (MI) areas few of these cells became also positive for α-SRA (α-sarcomeric actinin). These data suggest the coronary vessel adventitia as an endogenous niche for cardiac regeneration. Further studies are needed to identify mechanisms that govern this niche under physiological and pathological conditions, such as MI. We assume that a deep understanding of this stem cell niche could be the basis for the establishment of new therapeutic strategies.
Methods
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An expanded Methods section is available in the Online Data Supplement.
Isolation, Purification, and Differentiation of AoCs
Thoracic aorta of adult male and female C57BL/6 mice (2-4 months old) was dissected after PBS injection into the left ventricle. Subsequently, the thoracic aorta was enzymatically dispersed 21 into a single-cell suspension using 0.2% type 2 collagenase (Worthington, Lakewood) at 37°C for 90 minutes. After washing in PBS, which contained 5% fetal calf serum, cellular suspensions were passed through 70-μm pore size filters. Enrichment of Sca-1 + and Sca-1 − AoCs was achieved by Magnetic Cell Sorting (MACS; Miltenyi Biotec, Germany) using Sca-1 microbeads according to the manufacturer's instructions. Total AoCs, as well as sorted Sca-1 + and Sca-1 − AoCs, were cultured in modified EC growth medium (PromoCell, Germany) for 10 days. The medium was changed every day. Cells were maintained at 37°C in humid air with 5% CO 2 .
Chick/Mouse Chimeric Assay
A total of 2×10 3 AoCs labeled with carboxyfluorescein diacetate dye (in 10 μl PBS) were injected intracardially into chick embryos at developmental stages 16 to 17. Embryos were euthanized 4 days after injection and fixed with 4% paraformaldehyde at 4°C for 1 to 2 hours. Afterward, embryos were washed in PBS and transferred first to 10% then to 20% sucrose in PBS at 4°C. Finally, embryos were frozen in Tissue-Tek (Sakura, the Netherlands), cryosectioned at 7 μm and used for immunostaining of Flk1, Sca-1, Cx43 (connexin 43), and α-SRA.
Isolation and Differentiation of AoCs From Flk1 myr::mCherry and αMHC-mCherry Reporter Mice
AoCs were isolated and cultured from the thoracic aorta of adult male and female Flk1 myr::mCherry 22 (2-4 months old) and αMHC (α-myosin heavy chain)-mCherry (B6;D2-Tg[Myh6*-mCherry]2Mik/J obtained by The Jackson Laboratory) mice using isolation and cell culture conditions as described above. Immunofluorescence stainings were performed for Isl-1, α-SRA, CD34, CD31, F4/80, Flk1, and Sca-1. Movies were recorded using a Keyence microscope (Keyence BZ-9000, Japan).
Isolation, Purification, and Differentiation of Flk1
+ AoCs From UBC-GFP Mice
AoCs were isolated from thoracic aorta of adult male and female UBC-GFP mice 23 (2-4 months old) using standard isolation conditions. Afterward, AoCs were enriched for Flk1 + and Flk1 − fractions by MACS (Miltenyi Biotec, Germany) using Flk1 microbeads according to the manufacturer's instructions. MACS-sorted Flk1 + AoCs from UBC-GFP mice alone or mixed with total AoCs of non UBC-GFP mice were cultured under standard cell culture conditions. Immunofluorescence stainings were performed for Flk1 and α-SRA, and movies were recorded using a Keyence microscope (Keyence BZ-9000, Japan).
Aortic Sprouting Assay
Aortae of C57BL/6J were removed and cut into small rings as described. 12 The rings were then embedded in collagen gel using 48-well plates and cultured for 10 to 11 days in DMEM supplemented with 10% fetal calf serum. Afterward, rings were fixed using 4% paraformaldehyde for 30 minutes, removed from the plate, and embedded in paraffin. Tissue sections were used for immunohistochemistry for F4/80 and VEGF, either in single or in double staining combining peroxidase and fluorescence staining or fluorescence double staining.
Images were captured using the Keyence microscope and confocal laser scanning microscope (Nikon Eclipse Ti inverted microscope, Germany).
Mouse MI and Analysis of Coronary VesselResident Stem Cells
Male mice between 8 and 12 weeks of age were used for all experiments. C57BL/6J mice were purchased from Harlan Laboratories. Mice underwent left coronary artery ligation as described previously. 24 The study was done according to the regulations for animal experimentation and approved by the local government. Briefly, mice were anesthetized with isoflurane. After intubation, thoracotomy was performed and MI induced by ligation of the proximal part of the left coronary artery. Buprenorphine was administered for analgesia after surgery. For sham operation, thoracotomy was performed without ligating the coronary artery. Mice were euthanized 24 and 72 hours after MI, and heart tissue pieces were fixed using 4% paraformaldehyde and embedded in paraffin. From these, blocks tissue sections were prepared for immunohistochemistry. In summary, single or double immunostainings were performed for Isl-1, Flk1, CD34, CD31, Ki67, and αSMA (α-smooth muscle actin). In cases of double immunostainings, peroxidase staining combined with immunofluorescence was used.
Statistics
Paired groups were assessed for normal distribution using the STATISTICA 08 quantile plot test. Error bars indicate SDs, and the statistics were performed using either a paired Student t test (normal distribution) or a Wilcoxon test in the case of a non-normal distribution.
Results
Spontaneously Beating Cells Generated From the Mouse AoCs
We cultured mouse AoCs in modified endothelial cell growth medium. AoCs formed colony-like structures, and spontaneously beating Ao-bCMs appeared within these clusters around day 10 ( Figure 1A and 1B; Online Movie I). Next, we sorted AoCs into Sca-1 + and Sca-1 − fractions and found that Ao-bCMs arose only from the latter (Figure 1C through 1F; Online Movie II). In the last decade, cardiogenic potential has mainly been attributed to Sca-1 + cells. 25 However, this assumption was challenged because genetic fate mapping did not reveal a considerable contribution of Sca-1 + and c-Kit + cells to cardiomyogenesis, which was also confirmed by clinical trials. 26, 27 Our data show that AoCs cultured in StemSpan SFEM II (serum-free expansion medium II) medium built colony forming units with multipotent capacity differentiating into CD31 + , αSMA , and c-Kit + cells were preferentially found within the vascular adventitia ( Figure 1G ). These data are in line with published findings from different parts of human and mouse vessels. [12] [13] [14] Few single adventitial cells displayed a nuclear staining for the transcriptional factor Isl-1-a marker for cardiovascular progenitors predominantly localized in the second heart field 28 -and for the monocyte progenitor marker Ly6c ( Figure 1G ). These results were confirmed by flow cytometry ( 
Identification of Aortic Adventitia-Derived Cardiac Progenitors and Structural Characterization of Ao-bCMs
Similar to mature cardiomyocytes, AoC-derived Ao-bCMs expressed α-SRA in a cross-striated pattern ( Figure 3A ; Online Movie III). Embryonic stem cell-derived cardiomyocytes used as control displayed a similar staining pattern ( Figure 3A) . Double staining for α-SRA and cTNT revealed sarcomeric structures in Ao-bCMs exhibiting an expected sarcomere length of 2.5 µm (Figure 3B and inset). Electron microscopic analyses confirmed typical sarcomeric structures ( Figure 3C and 3D) . Additionally, Ao-bCMs showed centrally positioned nuclei and cellular branching (Online Figure IIA and IIA″) . Overall, Ao-bCMs displayed a complex sarcomeric organization similar to mature or pluripotent stem cell-derived cardiomyocytes. 31 Culturing mouse femoral artery-derived cells also resulted in α-SRA + beating cardiomyocytes (Online Movie IV) indicating a vessel type-independent existence of cardiogenic progenitors. Furthermore, a subset of α-SRA + Ao-bCMs and some α-SRA − AoCs exhibited Cx43 staining ( Figure 3E ) indicating gap junctional communication among Ao-bCMs, as well as between Ao-bCMs and surrounding supportive cells. Although, αSMA + and CD44 + cells were present in AoC cultures, such cells did not particularly accumulate within Ao-bCM containing colonies ( Figure 3F and 3G) . Thus, the cardiogenic AoCs characterized here represent a different subset of cardiac progenitors than the so-called mesoangioblasts, which were also isolated from the heart ventricle and aorta and shown to differentiate into cardiomyocytes. In contrast to adventitial cardiogenic AoCs, mesoangioblasts were demonstrated to express both CD44 and Sca-1. 6, 32, 33 Furthermore, c-Kit
− coronary vessel-derived cells were reported to differentiate into cells exhibiting cardiomyocyte markers. 19 We found a high accumulation of c-Kit + cells within AoC colonies containing Ao-bCMs ( Figure 3H ), but none of the c-Kit + AoCs was beating, and they did not coexpress α-SRA. Reversely, all α-SRA + Ao-bCMs were negative for c-Kit. Although changes in marker expression during AoC culture cannot be entirely excluded, the present data suggest that the c-Kit + subset of AoCs is rather supportive for the generation of Ao-bCMs than a source of them. Our findings are in line with the recently suggested paradigm about the role of c-Kit + in the heart. 34 Mature Ao-bCMs were negative for CD34, whereas cells with immature, nonstriated α-SRA staining pattern were weakly CD34 + ( Figure 3I ) indicating that CD34 + AoCs might give rise to Ao-bCMs. A considerable amount of cells within AoC clusters containing Ao-bCMs was Flk1 + , which was also weakly detectable in α-SRA + Ao-bCMs ( Figure 3J ). To better follow and characterize cardiogenic AoCs, we isolated them from Flk1 myr::mCherry mice. 22 On culture day 3, the marker for second heart field cardiac progenitors Isl-1 + AoCs immediately after aortic dispersion and 31% on culture day 10 (Online Figure IIL) . Next, we studied the gene expression profile of marker proteins of the developing heart, including MEF2C (myocyte enhancer factor 2C), 35 Isl-1, 36 and HCN4 (hyperpolarization-activated cyclic nucleotidegated channel 4), 37 and mature cardiomyocyte markers, such as troponin I and Actc1 (cardiac actin), using quantitative realtime polymerase chain reaction. All 3 embryonic heart markers were detected in both Sca-1 − and Sca-1 + AoCs on day 0 at significantly higher levels than on day 10, whereas troponin I and Actc1 as markers for mature cardiomyocyte were upregulated only in Sca-1 − AoCs on culture day 10 compared with day 0 (Figure 3P ; Online Figure IIM) . Moreover, expression of the cardiac marker proteins MLC-2a (myosin light chain 2 atrial) and MLC-2v (myosin light chain 2 ventricular) could be detected in a subset of α-SRA + Ao-bCMs (Online Figure III) . To confirm our data using a cardiac-specific reporter model, we cultured AoCs of αMHC-mCherry (B6;D2-Tg[Myh6*-mCherry]2Mik/J) reporter mice and demonstrated generation of spontaneously beating Ao-bCMs (Online Movie VIII) as described above. Consistently, double immunostaining revealed α-SRA + mCherry + cells (Online Figure IV) .
Functional Characterization of Ao-bCMs
To functionally characterize Ao-bCMs, we imaged calcium oscillations. Ao-bCMs exhibited characteristic fluorescence intensity transients as visualized by the Ca 2+ indicator Fluo-4-AM. Fluorescence intensity was measured on single and 2 connected beating Ao-bCMs (Figure 4A and 4B ; Online Movies IX, X, XIa, and XIb). A similar pattern of intracellular calcium transients was observed in embryonic stem cell-derived beating cardiomyocytes used as control (Online Figure VI; Online Movie XII). Electrophysiological measurements of Na + and K + currents showed characteristic voltage-dependent inward Na + and outward K + currents and large-amplitude action potentials ( Figure 4C and 4D) . Furthermore, we examined the receptiveness of Ao-bCMs for β-adrenergic drugs. In comparison with the baseline contraction rate, the β-adrenergic agonist isoproterenol increased the beating rate of Ao-bCMs significantly, whereas preincubation with the β-adrenergic receptor antagonist propranolol reversed the acceleration ( Figure 4E ; Online Movies XIII, XIV, and XV) suggesting that Ao-bCMs have functional characteristics of cardiomyocytes.
Crucial Role of Aortic Adventitia-Derived Macrophages, ECs, VEGF, and VEGFR-2 in the Generation of Ao-bCMs
Inflammatory pathways have been reported to induce endogenous reprograming of somatic cells. 38 Moreover, neonatal heart regeneration is accompanied by macrophagemediated inflammation. 39 Because vascular adventitial VW-SCs (vascular wall-resident stem cells) can differentiate into macrophages independently from bone marrow, 12, 14 we suspected a role of them in the cardiac differentiation of AoCs. Immunocytochemical studies revealed an accumulation of F4/80 + cells within Ao-bCM-containing cell clusters ( Figure 5A ). In vitro clodronate liposome treatment 40 depleted the macrophages efficiently ( Figure 5B ), whereas they remained present in PBS liposome-treated cultures ( Figure 5C ) used as negative control. Interestingly, α-SRA + beating cell clusters were absent on clodronate treatment ( Figure 5B ). These data indicate an important role of factors released by macrophages for the differentiation of AoCs into Ao-bCMs. Because macrophages producing VEGF 39 and VEGF receptor-2 (Flk1) + AoCs give rise to Ao-bCMs, we hypothesized that VEGF released by vascular adventitia-derived macrophages might be a key factor promoting the differentiation of AoCs into both Ao-bCMs and ECs, which in turn support cardiac differentiation. 41 Indeed, aortic adventitia-derived F4/80 + macrophages exhibited strong VEGF expression as demonstrated in aortic sprouting assays with subsequently performed single and double immunostainings for F4/80 and VEGF ( Figure 5D through 5F ).
To test our hypothesis, we treated AoC cultures with VEGF or the VEGF receptor-2 inhibitor lenvatinib (E7080). − AoCs on culture day 0 vs 10. Adult mouse heart tissue was used as a control. Gene expression levels in Sca-1 − AoCs on day 0 were set to 1. The data are presented as means±SD and are from 3 independent experiments. Statistics were performed using a paired Student t test. *P<0.05, **P<0.01, ***P<0.001.
E7080 treatment impaired Ao-bCM generation, whereas VEGF treatment increased the size of Ao-bCM-containing clusters and improved their synchronized beating (Online Movies XVI and XVII). This was accompanied by a higher number of CD31 + cells in cultured AoCs, which was significantly reduced by treatment with E7080 ( Figure 5G through 5I). Remarkably, CD31 + ECs strongly accumulated within Ao-bCM-containing AoC clusters ( Figure 5G ). Consistently, quantitative assessment revealed significantly higher numbers of both CD31 + and α-SRA + cells (Online Figure V) within the AoC colonies containing the beating Ao-bCMs after VEGF treatment and in untreated controls in comparison with the treatment with the VEGFR-2 (VEGF receptor-2) blocker E7080. These results indicate an essential involvement of VEGF in the generation of Ao-bCMs, probably because of both the higher number of ECs and the direct effect of VEGF on the differentiation of Flk1 + AoCs.
In Vivo Differentiation of AoCs Into Cardiomyocytes
Next, we tested the myocardial potential of AoCs in vivo and injected AoCs labeled with the long-term cell tracer carboxyfluorescein diacetate 42 into chick embryo hearts at developmental stages 16 to 17 43 (Online Movie XVIII). Three days after implantation, labeled AoCs were found adjacent to the myocardium (Figure 6A and 6B; Online Figure VIA through VID) as reported previously. 43 They were negative for Sca-1 ( Figure 6C ). Few implanted AoCs became α-SRA + (Figure 6D 
Coronary Vessel Adventitia-Resident Progenitors and Their Activation on MI
Finally, we set out to explore whether the vascular adventitial stem cell niche, [12] [13] [14] which was shown to be also present in coronary vessels, 13 is altered after MI and might contribute to myocardial regeneration. Our results demonstrate the presence of the vascular stem cell niche in the adventitial and periendothelial layers of all human and mouse heart vessel segments as exemplarily shown by CD34 staining on heart tissue sections ( Figure 7A and 7B) . Remarkably, the niche was remodeled after MI in both human and mouse heart tissue leading to altered CD34 staining ( Figure 7C and 7D). To study the differentiation pattern of coronary adventitia-resident stem cells on MI, we performed detailed analyses after mouse MI at 24 (data not shown) and 72 hours ( Figure 7E through 7K″) comparing the area directly at the myocardial infarct border (MIB), the myocardial infarct surroundings (MIS), and remote noninfarcted myocardial areas (NIA) within the same tissue section. Characteristic CD31 and αSMA staining identifying the vascular intima or media layers, respectively, was detectable in blood vessels of NIA, MIS, and MIB areas ( Figure 7E and 7F″) , whereas adventitial CD34 + cells were almost absent in MIB ( Figure 7E′ and 7F′) as compared with NIA ( Figure 7E and 7F) but increased in coronary vessels of MIS area ( Figure 7F″ ). These data indicate that the coronary adventitia was activated on MI, whereas intima and media layers appeared to be unchanged and morphologically intact. Furthermore, similar to aortic adventitia after ring assay Figure 5D through 5F), MI induced the generation of F4/80 + cells in coronary adventitia of MIS and MIB, whereas such cells were not detectable in NIA (Online Figure VIIIA through VIIID) . Interestingly, no F4/80 + cells were found within the coronary intima or media, which is indicative of only few or no infiltrating macrophages at this post-MI time point (Online Figure VIIIA + cells were observed in coronary intima and media layers in the MIS and MIB areas ( Figure 7G and 7G′) , which again suggests that these coronary vessel layers do not considerably contribute to the new cells appearing post-MI.
These data are in line with a recent publication showing that mature vascular pericytes and smooth muscle cells of multiple organs, including heart, do not behave as stem cells, even after being tested in injury models. 44 Remarkably, in double immunostainings for CD34 and α-SRA, CD34 + cells at the NIA and MIS remained in their coronary adventitial niche ( Figure 7H and 7H′ ), whereas they seemed to migrate from the adventitia into the infarcted area at the MIB and concurrently showed weaker CD34 staining than those cells remaining within their coronary vascular niche ( Figure 7H″ ). Furthermore, CD34 + α-SRA + cells were occasionally found only in the coronary adventitia at the MIS ( Figure 7H′ ) but not in the NIA (Figure 7H ) or at MIB ( Figure 7H″) . None of the CD34 + cells in the NIA expressed Isl-1 ( Figure 7I ), whereas a subset of coronary adventitial cells at the MIS ( Figure 7I′ ) and within the MI area at the MIB ( Figure 7I″ ) was Isl-1 + , and few of them were also CD34 + ( Figure 7I′ and 7I″ ). Both Flk1 + and CD34 + cells were present in the coronary adventitia of the NIA, and some of them were double positive for both CD34 and Flk1 ( Figure 7J ). Similar to CD34, none of the Flk1 + coronary adventitial cells of NIA ( Figure 7J′ ), MIS ( Figure 7J″ ), and MIB ( Figure 7J‴ ) were α-SRA + . Finally, Flk1 + cells at the NIA were Isl-1 − ( Figure 7K ), whereas those in the MIS partially exhibited nuclear Isl-1 staining (Figure 7K′ ). At the MIB, nearly all adventitial cells were found to express Flk1, and a considerable part of them was also Isl-1 + ( Figure 7K″ ).
Discussion
Here, we identified Flk1
− aortic adventitial cells (AoCs) as a cellular source for the generation of spontaneously beating Ao-bCMs with morphological and functional properties of cardiomyocytes without any genetic manipulation. Our data also show the presence of this VW-SC subpopulation in the adventitia of human and mouse coronary vessels. The population was activated to proliferate and achieved cardiac progenitor phenotype on mouse experimental MI. Using AoCs of Flk1-reporter mice in combination with immunophenotypic characterization, we demonstrated that a considerable part of Flk1 + AoCs expresses also CD34 and has the ability to deliver not only Ao-bCMs but also CD31 + ECs and F4/80 + macrophages in vitro. The depletion of aortic adventitia-derived macrophages, which were strongly positive for VEGF, resulted in the prevention of Ao-bCM generation. Consistently, VEGF treatment supported the generation AobCMs significantly as it increased (1) the number of α-SRA + beating cells and improved their synchronized beating, as well as (2) the number of CD31 + ECs, which have been reported to promote cardiomyocyte generation. 41 Accordingly, this effect was reversed by applying the Flk1 blocker E7080, which significantly reduced the number both cell types and prevented the generation of Ao-bCMs. Functional testing revealed that similar to mature cardiomyocytes, Ao-bCMs were responsive to β-adrenergic stimuli and showed calcium transients.
The innate regenerative capacity of the heart tissue is low and can, therefore, not contribute considerably to repair or replace the injured myocardium. Although recent studies suggested the presence of cardiac tissue-resident progenitors differentiating into cardiomyocyte under experimental conditions 19, 20 this endogenous capacity can apparently not be recruited under pathophysiological conditions, for example, after MI. MI with acute death of cardiomyocytes rapidly activates inflammatory processes, which (1) clear the cell and matrix debris from the infarcted area and (2) prepare the injured cardiac tissue for healing by generating proliferative signals 45 leading to angiogenesis, activation of mesenchymal cells, and cardiac fibroblasts. This process depends on orchestrated steps of cellular and molecular events that, however, result predominantly in the formation of scar tissue instead of generating functional cardiomyocytes. Beside several molecular and transcriptional factors that regulate cardiomyocyte differentiation, ECs and macrophages have also been reported to be critically involved in cardiac regeneration and healing, as well as survival of cardiomyocytes by preventing apoptosis. 41, 46 In this context, the particular impact of our results is that the Flk1 + subpopulation of AoCs delivered α-SRA + Ao-bCMs, ECs, and macrophages using Flk1-reporter mice, which together creates an indispensable microenvironment for the generation of Ao-bCMs. Results published by our group and others during the past 10 years demonstrated bone marrow-independent generation of vascular wall cells, as well as macrophages from vascular adventitial progenitors using in vitro and in vivo cell tracing experiments, genetic approaches and ex vivo analyses, bone marrow depletion and functional studies. [12] [13] [14] [15] 21 Our current data are in line with these findings and show that (1) both ECs and macrophages can be generated from the same Flk1 + VW-SC subpopulation under the same culture conditions as for Ao-bCMs, (2) their presence and accumulation in Ao-bCM-containing colonies is crucial for Ao-bCM generation, and (3) F4/80 + macrophages particularly accumulated within the adventitia of coronary vessels of the MI surrounding area while being not detectable in MI-free myocardium in the same heart tissue section. The impact of macrophages in cardiogenesis and cardiac regeneration is still controversial to some extent and represents a double-edged sword. Also the role of macrophages in cardiac inflammation is currently discussed. In several studies in the past, MI-or hypoxia-induced inflammatory reaction was suggested to worsen myocardial healing and thus to be a therapeutic target. 45 However, recent publications demonstrated also a beneficial role of macrophages, inducing regenerative signals that contributed to remuscularization of infarcted neonatal heart. 39 Furthermore, macrophage depletion during the first week after MI was shown to reduce the removal of necrotic cells, altered angiogenesis resulting in increased scar tissue formation, and clinically in higher mortality of macrophagedepleted mice. 47 In line with these results, our current data also show that a depletion of macrophages using clodronate application in vitro impairs the generation of Ao-bCMs. This effect is probably mediated by factors released from AoCs-derived macrophages, for example, VEGF, which is essential for ECs and angiogenesis. Macrophage-released factors, including VEGF, may also act directly on differentiating cardiac progenitors because they may possess corresponding receptors as shown for Flk1. Remarkably, macrophages were recently demonstrated to couple to cardiomyocytes via Cx43 and facilitate electric conductance in the heart. C, On MI, coronary adventitial cells are activated by signals released from the hypoxic myocardium close to the coronary vessel and can contribute to neoangiogenesis, cardiomyogenesis, and local inflammation. D, Considering the local interplay of these processes, it is conceivable that the endogenous myocardial renewing capacity is blocked by rapid inflammation and wound healing with subsequent scar tissue formation. Bv: coronary artery lumen; I: intima; M: media; A: adventitia; MC: myocardium; CPs: cardiac progenitors Flk1 (and its human orthologue KDR) has been suggested to label cardiac progenitors. 49, 50 In line with these data, our results identified the Flk1 + CD34 + cell population also in the adventitia of human and mouse coronary vessels and showed their mobilization from this niche into the neighboring myocardium accompanied by high proliferative activity on MI. Although further detailed studies are needed to decipher the molecular and cellular mechanisms unleashed by these processes and to assess their impact on cardiac repair and regeneration, the present data open new perspectives for an endogenous source of cardiac regeneration. This assumption is further underlined by our data showing that within the MI surrounding (MIS) and at the close MI border (MIB), a considerable number of coronary adventitiaderived Flk1 + and CD34 + cells became positive for Isl-1 suggesting their cardiovascular progenitor capacity. Indeed, few of these cells were found to become positive for α-SRA within 72 hours after MI. The transcription factor Isl-1 has been suggested as a marker for progenitors of second heart field, 51 whereas it was also shown to be transiently expressed in first heart field. Isl-1 + progenitors have the capacity to differentiate into cardiomyocytes, as well as into endothelial and smooth muscle cells. 47 The impact of Isl-1 for cardiogenesis is underlined by the results showing that Isl-1 deletion led to serious defects in the heart looping, the development of right ventricle, and outflow tract. 36 Further studies using genetic approaches and cell tracing studies in combination with MI and post-MI analyses during a longer time period as we observed here after MI are needed to better explore the cardioregenerative potential of Isl-1 + subset of Flk1 + CD34 + coronary adventitial cells.
In summary, the discovery of Ao-bCMs identifies Sca-1 −
CD34
+ Flk1 + aortic and coronary adventitia-derived cells ( Figure 8A and 8B) as a novel endogenous source for cardiac progenitors differentiating into cardiomyocytes in vitro and in vivo. Of clinical relevance, coronary vessel-resident CD34 +
Flk1
+ cells became Isl-1 + and partially also α-SRA + after MI ( Figure 8A and 8C) indicating their cardiomyogenic potential under pathological conditions. At this point, we cannot exclude a contribution of infiltrating cells, for example, macrophages to cardiac regenerative processes, but all cells that were found to be activated on MI were localized within the coronary adventitia. Interestingly, adventitia-derived inflammatory cells, such as macrophages, seem to play a crucial role in the regenerative processes, for example, by VEGF release and thus promoting neovascularization. However, because subtypes of macrophages, for example, infiltrating monocytes in contrast to yolk sac-derived tissue-resident macrophages, 52 were shown to promote wound healing accompanied by loss of cardiomyocyte and scar tissue formation, it is conceivable that such processes block the endogenous cardiac renewing capacity ( Figure 8D ), 8 which might explain why coronary adventitial cardiac progenitors do not achieve terminal differentiation into cardiomyocytes endogenously.
Based on the knowledge gained from our study, future therapeutic strategies should focus on manipulating coronary adventitia-derived inflammatory, angiogenic, and cardiomyogenic signals to orchestrate these processes toward functional myocardial regeneration and repair.
